Common diabetes drug fails to improve walking performance in peripheral artery disease patients
A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, according to results from a major U.S. clinical trial published in JAMA.
Jan 20, 2026
0
11









